Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Operating Leases: 2022-2025

Historic Operating Leases for Biodesix (BDSX) over the last 4 years, with Sep 2025 value amounting to $24.4 million.

  • Biodesix's Operating Leases fell 3.09% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year decrease of 3.09%. This contributed to the annual value of $24.8 million for FY2024, which is 1.33% down from last year.
  • Per Biodesix's latest filing, its Operating Leases stood at $24.4 million for Q3 2025, which was up 1.25% from $24.1 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Operating Leases registered a high of $25.5 million during Q2 2024, and its lowest value of $1.2 million during Q1 2022.
  • In the last 3 years, Biodesix's Operating Leases had a median value of $24.6 million in 2023 and averaged $23.1 million.
  • Per our database at Business Quant, Biodesix's Operating Leases soared by 922.85% in 2023 and then dropped by 5.37% in 2025.
  • Quarterly analysis of 4 years shows Biodesix's Operating Leases stood at $5.3 million in 2022, then soared by 378.93% to $25.2 million in 2023, then fell by 1.33% to $24.8 million in 2024, then dropped by 3.09% to $24.4 million in 2025.
  • Its Operating Leases was $24.4 million in Q3 2025, compared to $24.1 million in Q2 2025 and $24.5 million in Q1 2025.